Mission-driven venture capital fund of the American Cancer Society
Employees: 11-50
Investment Type: Venture Capital
Portfolio 17
| Date | Name | Website | Total Raised | Location |
| - | Castle Bio... | castlebios... | $43.6M | United Sta... |
| - | Interius | interiusbi... | $76M | United Sta... |
| - | Mercy BioA... | mercybio.c... | $41M | United Sta... |
| - | Lunit | lunit.io | $237M | South Kore... |
| - | Checkmate ... | checkmatep... | $154M | United Sta... |
| - | TailorMed | tailormed.... | $45M | United Sta... |
| - | Freenome | freenome.c... | $1.05B | United Sta... |
| - | Immunitas ... | immunitast... | $97M | United Sta... |
| - | CellCentri... | cellcentri... | $51M | United Kin... |
| - | Naveris, I... | naveris.co... | $51M | United Sta... |
Show more
News 28
| Date | Title | Description |
| 03.11.2023 | BrightEdge Annual Report 2022 | Click the red "View Report" link to read the full report |
| 03.11.2023 | CellCentric to present haem clinical data at ASH | Cambridge, UK, November 4th, 2022 – CellCentric, a privately owned, clinical stage biotechnology com... |
| - | BrightEdge joins world class investors to help accelerate ea... | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Freenome, a biotechnology company that has pioneered t... |
| - | Checkmate Pharmaceuticals Announces Pricing of Initial Publi... | CAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), ... |
| - | FDA Grants Alpheus Medical Orphan Drug and Fast Track Design... | See original press release here. |
| - | American Cancer Society’s Impact Venture Capital Arm Secures... | For more information, contact: Michele Money-Carson michele.money-carson@cancer.org |
| - | American Cancer Society’s Impact Venture Capital Fund Releas... | Click the link to read full report |
| - | BrightEdge Announces Second Investment in Freenome, Technolo... | BrightEdge, LLC today announced a second investment in Freenome, a San Francisco-based biotechnology... |
| - | Immunitas Therapeutics Completes $58 Million Series B Financ... | Waltham, Mass., August 18, 2021 – Immunitas Therapeutics (“Immunitas”), a single cell genomics-based... |
| - | TailorMed Extends Funding Series to $25 Million to Continue ... | NEW YORK--(BUSINESS WIRE)--TailorMed Medical Ltd., a leading patient financial navigation technology... |
Show more
Mentions in press and media 4
| Date | Title | Description | Source |
| 27.02.2024 | Freenome scores $254M to advance its cancer-detection blood ... | The San Francisco company readies to reveal its first clinical study results in the near term When i... | vator.tv/n... |
| 20.02.2024 | Freenome's $254M Boost for Early Cancer Detection | Freenome, a biotech company in San Francisco, just secured a massive $254M in funding to advance the... | parsers.vc... |
| 15.02.2024 | Freenome Raises $254M to Accelerate Early Cancer Detection P... | What You Should Know: – Freenome, a leader in blood-based early cancer detection, has raised $254M i... | hitconsult... |
| 22.08.2023 | BrightEdge’s Impact: Transforming Cancer Care and Changing L... | Key Takeaways: ACS BrightEdge’s annual report reveals its portfolio of 18 companies could potentiall... | eustartup.... |